Excessive crying Completed Phase 4 Trials for Lamotrigine (DB00555)

IndicationStatusPhase
DBCOND0100150 (Excessive crying)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04523935Excessive Crying in Children With Cerebral Palsy and Communication DeficitsSupportive Care